: : : 2007-06-18 to 2007-06-24
FDA Requests Box Warnings for MRI Contrast Agents
June 22, 2007 12:33
May 2007-- The U.S. Food and Drug Administration (FDA) has asked manufacturers to include a new boxed warning on the product labeling of all gadolinium-based contrast agents which are used to enhance the quality of magnetic resonance imaging (MRI).The requested... (Read Article)
